ProPhase Labs, Inc. logo

PRPHProPhase Labs, Inc.

PRPH Stock Price, Valuation & Chart | ProPhase Labs, Inc.

Compare

PRPH Historical price chart

PRPH Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization283.13K
PE Ratio-0.01
EPS-3.01
Trading Volume117.53K
Today's High/Low0.02/0.02
Dividend Yield0.00
52 Week High/Low6.7/0.02
Shares Outstanding14.02M
PRPH Financial Statement
PRPH Analyst ratings
PRPH Analysis & performance metrics

PRPH Company profile

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary…

PRPH Management team

Management
Lance Bisesar
Corporate Controller
Kamal ObbadCTO
Senior Vice President and Director of Sales & Marketing - Nebula Genomics
Jason Karkus
President of Nebula Genomics
Ted William KarkusCEO
Chairman & Chief Executive Officer
Total 4 executives

PRPH Frequently asked questions

What is ProPhase Labs, Inc. (PRPH) Stock Price?

Current stock price of ProPhase Labs, Inc. (PRPH) stock is $0.020. The stock price is -3.81% lower in the session. The intraday range can be seen from this page. Volume of ProPhase Labs, Inc. (PRPH) stock is 117.53K.

Last updated at 02 Sept 2026, 07:43 pm.

Why is the ProPhase Labs, Inc. (PRPH) stock price going up or down today?

The stock price of ProPhase Labs, Inc. (PRPH) can change with earnings, company news, and overall market sentiment. ProPhase Labs, Inc. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the ProPhase Labs, Inc. stock expensive at its current price?

Whether ProPhase Labs, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PRPH on this page is -0.01. EPS on this page is -3.01. Compare those figures with peers and growth expectations before deciding if the current ProPhase Labs, Inc. price is justified.

How has the stock price of ProPhase Labs, Inc. (PRPH) performed historically?

Historical performance for ProPhase Labs, Inc. (PRPH) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PRPH reacted to past earnings and market events.

Should I buy ProPhase Labs, Inc. (PRPH) stock, at this price?

Buying ProPhase Labs, Inc. (PRPH) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.